population according to the SEER database (adjusted for age, gender, and race).1 In controlled trials of other TNF blockers in adult subjects at higher risk for malignancies (i.e., subjects with COPD with a significant smoking history and cyclophosphamide-treated subjects with Wegeners granulomatosis), a greater portion of malignancies occurred in the TNF blocker group compared to the control group
Knowing what to look for helps prevent wasted money and unnecessary health risks
Journal of the American Medical Association
Repeated exposure to smoke can eventually lead to noticeable changes in voice quality
[5] Older, C., Diesel, A., Patterson, A., Meason-Smith, C., Johnson, T., & Mansell, J